Extended nucleocapsid protein is cleaved from the Gag-Pol precursor of human immunodeficiency virus type 1

Journal of General Virology

Volumn 82, Issue 3, 2001, Pages 581-590

  Chen, N ^a   Morag, A ^a   Almog, N ^a   Blumenzweig, I ^a   Dreazin, O ^a   Kotler, M ^a  

^a HEBREW UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; GAG PROTEIN; INTEGRASE; MESSENGER RNA; NUCLEOCAPSID PROTEIN; PEPTIDE; POL PROTEIN; POLYPROTEIN; PROTEIN PRECURSOR; PROTEINASE; RNA DIRECTED DNA POLYMERASE; STRUCTURAL PROTEIN; VIRUS ENZYME; VIRUS PROTEIN; VIRUS RNA;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; BACTERIUM; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; EUKARYOTE; FRAMESHIFT MUTATION; GENE MUTATION; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; OPEN READING FRAME; PRECURSOR; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN PROCESSING; PROTEIN STRUCTURE; PROTEIN TRANSPORT; RNA TRANSLATION; SEQUENCE ANALYSIS; STRUCTURE ANALYSIS; VIRUS GENOME;

ANIMALIA; BACTERIA (MICROORGANISMS); EUKARYOTA; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES;

EID: 0035112594     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/0022-1317-82-3-581     Document Type: Article

References (34)

1. A putative alphahelical structure which overlaps the capsid-p2 boundary in the human immunodeficiency virus type 1 Gag precursor is crucial for viral particle assembly
2. Pol protease fusion protein is present in mature particles of immunodeficiency virus type 1
3. Ribosomal frameshifting at the Gag Pol junction in avian leukemia sarcoma virus forms a novel cleavage site
4. Human immunodeficiency virus type 1 Vif-derived peptides inhibit the viral protease and arrest virus production
5. Sequence-specific resonance assignments of the H-NMR spectra and structural characterization solution of the HIV-1 transfer protein p6
6. Characterization of human immunodeficiency virus type 1 (HIV-1) particles that express protease-reverse transcriptase fusion proteins
7. Expression of exogenous DNA in mammalian cells
8. Peptides derived from HIV-1 Vif: A non-substrate based novel type of HIV-1 protease inhibitors
9. Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase
10. Improved electrophoresis and transfer picogram amounts of protein with hemoglobin
11. Analysis of proteins and peptides purified from sucrose gradient banded HTLV-III
12. Gag proteins of the highly replicative MN strain of the human immunodeficiency virus type 1: Post translational modifications, proteolytic processing and complete amino acid sequences
13. Characterization of ribosomal frameshifting in HIV-1 gag-pol expression
14. Overexpression of the HIV-1 Gag-Pol proteins results in intracellular activation of HIV-1 protease and inhibition of assembly and budding of virus-like particles
15. Human immunodeficiency virus type 1 gag protease fusion proteins are enzymatically active
16. The spacer peptide between human immunodeficiency virus capsid and nucleocapsid proteins is essential for ordered assembly and viral infectivity
17. Kinetics and mechanism of autoprocessing of human immunodeficiency virus type 1 protease from an analog of the Gag-Pol polyprotein
18. Autoprocessing of HIV-1 protease is tightly coupled to protein folding
19. Manipulation and expression of the maize zein storage proteins in Escherichia coli
20. The P2 domain of human immunodeficiency virus type 1 Gag regulates sequential proteolytic processing and is required to produce fully infectious virions
21. Intrinsic activity of precursor forms of HIV-1 proteinase
22. Complete nucleotide sequence of the AIDS virus, HTLV-III
23. Rational design of peptide-based HIV proteinase inhibitors
24. Processed enzymatically active protease (p15gag) of avian retrovirus obtained in an E. coli system expressing a recombinant precursor (Pr25lac-delta gag)
25. Requirements for incorporation of Pr160 gag-pol from human immunodeficiency virus type 1 into virus-like particles
26. Use of T7 RNA polymerase to direct expression of cloned genes
27. Synthesis, assembly, and processing of viral proteins
28. Cleavage of human immunodeficiency virus type 1 proteinase from the N-terminally adjacent p6 protein is essential for efficient Gag polyprotein processing and viral infectivity
29. Mutagenesis of protease cleavage sites in the human immunodeficiency virus type 1 gag polyprotein
30. The pUC plasmids, an M13mp7-derived system for insertion mutagenesis and sequencing with synthetic universal primers
31. Proteolytic processing and particle maturation
32. The gag precursor contains a specifif HIV-1 protease cleavage site between the NC(P7) and p1 proteins
33. Domains upstream of the protease (PR) in human immunodeficiency virus type 1 Gag-Pol influence PR autoprocessing
34. Proteolytic activity of novel human immunodeficiency virus type 1 proteinase proteins from a precursor with a blocking mutation at the N terminus of the PR domain